Talzenna 00069-0454
Generic: Talazoparib
Product NDC
00069-0454- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Dosage Form
- Capsule, Liquid Filled
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 17, 2024
- Listing Expires
- December 31, 2027
- Application
- NDA217439
Need to source Talzenna? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Talazoparib Tosylate | .35 mg/1 |
Drug Class
Poly(ADP-Ribose) Polymerase Inhibitor [EPC]Poly(ADP-Ribose) Polymerase Inhibitors [MoA]
Packaging Options(1)
30 CAPSULE, LIQUID FILLED in 1 BOTTLE (0069-0454-30)